STOCK TITAN
  1. Home
  2. Sec-filings
  3. DCGO
  4. [8-K] DocGo Inc. Reports Material Event

DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DocGo Inc. extended the expiration date of its existing share repurchase program from June 30, 2026 to December 31, 2026. The program continues to allow purchases of up to $26 million of common stock through open market or privately negotiated transactions and related methods. Repurchases may be funded from cash, future cash flow or borrowings, and the program can be modified, suspended or discontinued at any time.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Share repurchase authorization $26 million Maximum common stock buybacks under existing program
Original program expiration June 30, 2026 Prior end date for share repurchase program
Extended program expiration December 31, 2026 New end date for share repurchase program
Company phone number (844) 443-6246 Registrant contact information
share repurchase program financial
"approved an extension of the expiration date of the Company’s current share repurchase program"
A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.
Rule 10b5-1 trading plans regulatory
"including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs"
Rule 10b5-1 trading plans are written, pre-arranged instructions that allow company insiders (such as executives or directors) to automatically buy or sell their company's stock at specified times or under set conditions, like a standing instruction or automated thermostat for trades. They matter to investors because these plans provide a legal defense against insider‑trading accusations and create predictable insider trading patterns that can help signal whether sales are routine portfolio management or potentially meaningful to the company’s outlook.
accelerated share repurchase programs financial
"or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs"
An accelerated share repurchase program is a way for a company to buy back its own shares quickly, often within a short period. It typically involves a financial partner temporarily purchasing a large number of shares on behalf of the company, which are then gradually returned to the company’s treasury. This process allows the company to boost its stock price and earnings per share, making it important for investors tracking company performance.
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
0001822359FALSE00018223592026-06-262026-06-26


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________

FORM 8-K
___________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 26, 2026
___________________________________

DOCGO INC.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
001-39618
85-2515483
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
685 Third Avenue, 9th Floor, New York, New York
10017
(Address of principal executive offices)
(Zip Code)
(844) 443-6246
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.0001 per share
DCGO
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01 Regulation FD Disclosure.

On June 26, 2026, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from June 30, 2026 to December 31, 2026. As previously disclosed, pursuant to the Repurchase Program, the Company may purchase up to $26 million in shares of the Company’s common stock. Other than the extension of the program’s expiration date, no changes were made to the Repurchase Program.

Under the terms of the Repurchase Program, as extended, the Company may continue to purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an “open window” and when the Company does not possess material non-public information.

The timing and actual number of shares repurchased under the Repurchase Program will depend on a variety of factors, including stock price, trading volume, market conditions, corporate and regulatory requirements and other general business considerations. The Repurchase Program may be modified, suspended or discontinued at any time without prior notice.

Repurchases under the Repurchase Program may be funded from the Company’s existing cash and cash equivalents, future cash flow or proceeds of borrowings or debt offerings.

The information in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


DOCGO INC.
By:
/s/ Norman Rosenberg
Name:
Norman Rosenberg
Title:
Chief Financial Officer and Treasurer

Date: July 2, 2026

2

Source: View Original Filing on SEC EDGAR

FAQ

What did DocGo (DCGO) change about its share repurchase program?

DocGo extended the expiration of its existing share repurchase program to December 31, 2026. All other terms remain the same, including the ability to buy back up to $26 million of common stock through various transaction methods over time.

How large is DocGo’s current share repurchase program?

DocGo’s share repurchase program authorizes the purchase of up to $26 million of its common stock. The company can execute these repurchases over time through open market trades, privately negotiated deals, Rule 10b5-1 plans or accelerated share repurchase programs.

Until when is DocGo’s share repurchase program now effective?

DocGo’s share repurchase program now runs through December 31, 2026. This extends the previous June 30, 2026 expiration date, giving the company more time to repurchase shares under the existing $26 million authorization if market and business conditions warrant.

How can DocGo execute share repurchases under this program?

DocGo may repurchase shares via open market transactions, privately negotiated deals, Rule 10b5-1 trading plans or accelerated share repurchase programs. The company intends to act during open trading windows and when it does not possess material non-public information, consistent with regulatory requirements.

What factors will influence DocGo’s actual share repurchases?

Actual repurchases will depend on stock price, trading volume, market conditions, corporate and regulatory requirements and other business considerations. The company also retains the right to modify, suspend or discontinue the program at any time without prior public notice.

How does DocGo plan to fund its share repurchase program?

DocGo may fund repurchases using existing cash and cash equivalents, future cash flow or proceeds from borrowings or debt offerings. This flexibility lets the company choose among internal resources and external financing depending on its capital needs and market conditions.

Filing Exhibits & Attachments

4 documents

Other Documents